Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee
Open Access
- 16 November 2020
- journal article
- review article
- Published by BMJ in Journal for ImmunoTherapy of Cancer
- Vol. 8 (2) , e001583
Abstract
Immunotherapy is now a cornerstone for cancer treatment, and much attention has been placed on the identification of prognostic and predictive biomarkers. The success of biomarker development is dependent on accurate and timely collection of biospecimens and high-quality processing, storage and shipping. Tumors are also increasingly used as source material for the generation of therapeutic T cells. There have been few guidelines or consensus statements on how to optimally collect and manage biospecimens and source material being used for immunotherapy and related research. The Society for Immunotherapy of Cancer Surgery Committee has brought together surgical experts from multiple subspecialty disciplines to identify best practices and to provide consensus on how best to access and manage specific tissues for immuno-oncology treatments and clinical investigation. In addition, the committee recommends early integration of surgeons and other interventional physicians with expertise in biospecimen collection, especially in clinical trials, to optimize the quality of tissue and the validity of correlative clinical studies in cancer immunotherapy.Keywords
This publication has 124 references indexed in Scilit:
- Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cellsNature Medicine, 2013
- The Shape of the Lymphocyte Receptor Repertoire: Lessons from the B Cell ReceptorFrontiers in Immunology, 2013
- Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic functionJournal of Translational Medicine, 2011
- Cancer and Inflammation: Promise for Biologic TherapyJournal of Immunotherapy, 2010
- Adequacy and complications of computed tomography-guided core needle biopsy on non-small cell lung cancers for epidermal growth factor receptor mutations demonstration: 18-gauge or 20-gauge biopsy needleLung Cancer, 2010
- Developing a Tissue Resource to Characterize the Genome of Pancreatic CancerWorld Journal of Surgery, 2009
- Comparison of 3D and 2D tumor models reveals enhanced HER2 activation in 3D associated with an increased response to trastuzumabOncogene, 2008
- Evaluation of the Sentinel Immunized Node for Immune Monitoring of Cancer VaccinesAnnals of Surgical Oncology, 2008
- A procedure for tissue freezing and processing applicable to both intra-operative frozen section diagnosis and tissue banking in surgical pathologyVirchows Archiv, 2008
- Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4Journal of Clinical Oncology, 2006